Water intoxication induced by low-dose cyclophosphamide in two patients with systemic lupus erythematosus

被引:31
作者
Salido, M
Macarron, P
Hernández-García, C
D'Cruz, DP [1 ]
Khamashta, MA
Hughes, GRV
机构
[1] St Thomas Hosp, Rayne Inst, Lupus Res Int, London SE1 7EH, England
[2] Hosp Clin San Carlos, Serv Rheumatol, Madrid, Spain
关键词
cyclophosphamide; lupus nephritis; water intoxication;
D O I
10.1191/0961203303lu421cr
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Cyclophosphamide(CY) is an alkylating agent used to treat a variety of autoimmune disorders. Water intoxication is a well-known complication of high-dose intravenous (i.v.) CY, but is rare in patients treated with low dose i.v. CY. We describe two patients with lupus nephritis and water intoxication following low dose i.v. CY. The first patient was treated with oral prednisolone and azathioprine for eight weeks with inadequate response and persistent renal inflammatory activity. Eight hours after the first i.v. CY pulse she had a grand mal seizure. The second patient had WHO class III lupus nephritis, and after a single i.v. CY pulse developed vomiting, diarrhoea and grand mal seizures. They were both fluid-restricted and their serum sodium levels returned to normal. In conclusion, even at low doses i.v. CY may induce hyponatremia related to inappropriate antidiuretic hormone secretion. This potentially life-threatening complication of i.v. CY could be minimized by avoidance of overhydration following pulse i.v. CY.
引用
收藏
页码:636 / 639
页数:4
相关论文
共 21 条
[1]   STUDIES ON THE ANTI-DIURETIC EFFECT OF CYCLOPHOSPHAMIDE - VASOPRESSIN RELEASE AND SODIUM-EXCRETION [J].
BODE, U ;
SEIF, SM ;
LEVINE, AS .
MEDICAL AND PEDIATRIC ONCOLOGY, 1980, 8 (03) :295-303
[2]   WATER-INTOXICATION FOLLOWING MODERATE-DOSE INTRAVENOUS CYCLOPHOSPHAMIDE [J].
BRESSLER, RB ;
HUSTON, DP .
ARCHIVES OF INTERNAL MEDICINE, 1985, 145 (03) :548-549
[3]  
BROCK N., 1967, CANCER CHEMOTHER REP, V51, P315
[4]  
BUCKNER CD, 1972, CANCER, V29, P357, DOI 10.1002/1097-0142(197202)29:2<357::AID-CNCR2820290215>3.0.CO
[5]  
2-M
[6]  
Campbell DM, 2000, J PEDIATR ENDOCR MET, V13, P673
[7]   PHARMACOKINETICS OF CYCLOPHOSPHAMIDE IN MAN [J].
COHEN, JL ;
JAO, JY ;
JUSKO, WJ .
BRITISH JOURNAL OF PHARMACOLOGY, 1971, 43 (03) :677-&
[8]  
DCruz D, 1997, CLIN EXP RHEUMATOL, V15, P275
[9]  
DEFRONZO RA, 1974, CANCER-AM CANCER SOC, V33, P483, DOI 10.1002/1097-0142(197402)33:2<483::AID-CNCR2820330224>3.0.CO
[10]  
2-P